Subject : Understanding perception and Usage of Fixed-dose combination in Management of Type 2 Diabetes Mellitus
At Sun Pharma, we are always keen to keep you ahead in knowledge updatation as well as in helping you to improve quality of clinical decision making, while achieving this objective we always undertake various surveys and studies to understand current clinical practices, perceptions about existing therapeutic options and also possible future challenges in the management of disease burden. The below survey is aimed to understand the same and the summary or outcome from the same will be used to build our in-clinic communication, future knowledge updation program content and also to evaluate future therapeutic options. Your responses will be used at aggregate level.
In below described survey the primary objective is to have practice-based opinion from Clinicians on the current status in Indian settings. we will like to understand your perception and usage for Fixed-dose combination in management of type 2 diabetes mellitus. As you know, Type 2 diabetes mellitus (T2DM) is a progressive disease with multifactorial etiology. The first-line therapy includes monotherapy (with metformin), which often fails to provide effective glycemic control, necessitating the addition of add-on therapy. In this regard, multiple single-dose agents formulated as a single-dose form called. fixed-dose combinations (FDCs) have been evaluated for their safety, efficacy, and tolerability.
|
}}){kind=logo}
}})